Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

The impact of helminths on the response to immunization and on the incidence of infection and disease in childhood in Uganda: design of a randomized, double-blind, placebo-controlled, factorial trial of deworming interventions delivered in pregnancy an...
ELLIOTT, AM; Kizza, M; Quigley, MA; Ndibazza, J; Nampijja, M; Muhangi, L; Morison, L; Namujju, PB; Muwanga, M; Kabatereine, N; WHITWORTH, JA G;
2007
Clinical trials (London, England), (2007).4 1 10.1177/1740774506075248.
Interaction between Bluetongue virus outer capsid protein VP2 and vimentin is necessary for virus egress.
BHATTACHARYA, B; Noad, RJ; ROY, P;
2007
Virology journal, (2007).4 1 10.1186/1743-422X-4-7.
The identification of two protective DNA vaccines from a panel of five plasmid constructs encoding Brucella melitensis 16M genes.
Commander, NJ; Spencer, SA; WREN, BW; MacMillan, AP;
2007
Vaccine, (2007).25 1 10.1016/j.vaccine.2006.07.046.
Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England.
Cohen, C; White, JM; Savage, EJ; GLYNN, JR; Choi, Y; Andrews, N; Brown, D; Ramsay, ME;
2007
Emerging infectious diseases, (2007).13 1 10.3201/eid1301.060649.
The cost-effectiveness of Herpes Zoster vaccination among elderly in England and Wales (to be nominated).
Van Hoek, AJ; Melegaro, A; Gay, N; EDMUNDS, J;
2007
EUROPEAN JOURNAL OF PUBLIC HEALTH, (2007).17,
'Non-specific effects of vaccines'--an important analytical insight, and call for a workshop.
FINE, PE M; SMITH, PG;
2006
Tropical medicine & international health, (2006).12 1 10.1111/j.1365-3156.2006.01794.x.
Perspective: determinants of the severity of poliovirus outbreaks in the post eradication era.
FINE, PE M; Ritchie, S;
2006
Risk analysis, (2006).26 6 10.1111/j.1539-6924.2006.00855.x.
The influence of previous exposure to environmental mycobacteria on the interferon-gamma response to bacille Calmette-Guérin vaccination in southern England and northern Malawi.
Weir, RE; Black, GF; Nazareth, B; FLOYD, S; Stenson, S; Stanley, C; BRANSON, K; Sichali, L; Chaguluka, SD; Donovan, L; CRAMPIN, AC; FINE, PE M; DOCKRELL, HM;
2006
Clinical and experimental immunology, (2006).146 3 10.1111/j.1365-2249.2006.03222.x.
Mass vaccination: when and why.
HEYMANN, DL; Aylward, RB;
2006
Current topics in microbiology and immunology, (2006).304, 10.1007/3-540-36583-4_1.
Revaccination with Bacillus Calmette-Guerin (BCG) vaccine does not reduce morbidity from malaria in African children.
Rodrigues, A; SCHELLENBERG, JA; Roth, A; Benn, CS; Aaby, P; GREENWOOD, B;
2006
Tropical medicine & international health, (2006).12 2 10.1111/j.1365-3156.2006.01766.x.